September 22, 2025 Baricitinib for Ankylosing Spondylitis: New Hope in Treatment Baricitinib emerges as a promising oral JAK inhibitor for ankylosing spondylitis, offering new efficacy data, safety insights, and a clear place alongside existing biologics. Continue Reading
